LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.25 | 27.76 | 196 | 6873 | 0.0285 | 0.2786 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.25 | 27.76 | 2168 | 6873 | 0.3154 | 0.7299 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 93.96 | 27.76 | 1755 | 6849 | 0.2562 | 0.6851 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 93.96 | 27.76 | 1768 | 6849 | 0.2581 | 0.6866 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 93.96 | 27.76 | 179 | 6849 | 0.0261 | 0.2643 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 93.96 | 27.76 | 2163 | 6849 | 0.3158 | 0.7300 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 95.66 | 27.76 | 1822 | 6712 | 0.2714 | 0.6963 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 95.66 | 27.76 | 1838 | 6712 | 0.2738 | 0.6982 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 95.66 | 27.76 | 193 | 6712 | 0.0288 | 0.2775 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 95.66 | 27.76 | 2174 | 6712 | 0.3239 | 0.7346 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 1.95 | 27.76 | 435 | 225 | 1.9321 | 1.4874 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 1.95 | 27.76 | 733 | 225 | 3.2557 | 1.9566 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 3.66 | 27.76 | 531 | 283 | 1.8702 | 1.4104 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 3.66 | 27.76 | 801 | 283 | 2.8211 | 1.7246 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 5.36 | 27.76 | 587 | 320 | 1.8323 | 1.3745 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 5.36 | 27.76 | 2 | 320 | 0.0062 | -0.5255 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 5.36 | 27.76 | 909 | 320 | 2.8375 | 1.6877 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.06 | 27.76 | 646 | 360 | 1.7944 | 1.3427 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.06 | 27.76 | 3 | 360 | 0.0083 | -0.4522 | MN20160318_Q01 | L22 |